125 related articles for article (PubMed ID: 7689144)
1. Antiestrogens inhibit the replication of the retroviral Moloney murine leukemia virus in vitro.
Chailleux C; Mesange F; Bayard F; Prats AC; Faye JC
Mol Pharmacol; 1993 Aug; 44(2):324-7. PubMed ID: 7689144
[TBL] [Abstract][Full Text] [Related]
2. Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
Mesange F; Delarue F; Puel J; Bayard F; Faye JC
Mol Pharmacol; 1996 Jul; 50(1):75-9. PubMed ID: 8700122
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogen inhibition of prolactin-induced growth of the Nb2 rat lymphoma cell line.
Biswas R; Vonderhaar BK
Cancer Res; 1989 Nov; 49(22):6295-9. PubMed ID: 2804977
[TBL] [Abstract][Full Text] [Related]
4. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
Watts CK; Sutherland RL
Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
[TBL] [Abstract][Full Text] [Related]
5. Characterization and quantitation of antiestrogen binding sites in estrogen receptor-positive and -negative human breast cancer cell lines.
Miller MA; Katzenellenbogen BS
Cancer Res; 1983 Jul; 43(7):3094-100. PubMed ID: 6850618
[No Abstract] [Full Text] [Related]
6. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
7. Both the immunosuppressant SR31747 and the antiestrogen tamoxifen bind to an emopamil-insensitive site of mammalian Delta8-Delta7 sterol isomerase.
Paul R; Silve S; De Nys N; Dupuy PH; Bouteiller CL; Rosenfeld J; Ferrara P; Le Fur G; Casellas P; Loison G
J Pharmacol Exp Ther; 1998 Jun; 285(3):1296-302. PubMed ID: 9618436
[TBL] [Abstract][Full Text] [Related]
8. Interaction of chemopreventive agents with hormone receptors.
Wiseman H
IARC Sci Publ; 1996; (139):159-64. PubMed ID: 8923028
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of the microsomal tamoxifen binding site.
Kedjouar B; de Médina P; Oulad-Abdelghani M; Payré B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
J Biol Chem; 2004 Aug; 279(32):34048-61. PubMed ID: 15175332
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.
Gulino A; Pasqualini JR
Cancer Res; 1982 May; 42(5):1913-21. PubMed ID: 7066903
[TBL] [Abstract][Full Text] [Related]
12. Decay of Moloney leukemia virus production after enucleation of chronically infected mouse cells.
Ber R; Fenyo EM; Nexø BA; Skoog L
Isr J Med Sci; 1981 Aug; 17(8):690-6. PubMed ID: 6169684
[TBL] [Abstract][Full Text] [Related]
13. Induction of mitochondria-involved apoptosis in estrogen receptor-negative cells by a novel tamoxifen derivative, ridaifen-B.
Nagahara Y; Shiina I; Nakata K; Sasaki A; Miyamoto T; Ikekita M
Cancer Sci; 2008 Mar; 99(3):608-14. PubMed ID: 18167132
[TBL] [Abstract][Full Text] [Related]
14. Basic guide to the mechanisms of antiestrogen action.
MacGregor JI; Jordan VC
Pharmacol Rev; 1998 Jun; 50(2):151-96. PubMed ID: 9647865
[TBL] [Abstract][Full Text] [Related]
15. Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.
Gu J; Villanueva RA; Snyder CS; Roth MJ; Georgiadis MM
J Mol Biol; 2001 Jan; 305(2):341-59. PubMed ID: 11124910
[TBL] [Abstract][Full Text] [Related]
16. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
Lee TH; Chuang LY; Hung WC
Oncogene; 2000 Aug; 19(33):3766-73. PubMed ID: 10949931
[TBL] [Abstract][Full Text] [Related]
17. Replication of a Moloney murine leukemia virus mutant lacking the ELP binding site.
Coulombe J; Dubé M; Gray DA
Virology; 1994 Aug; 203(1):162-5. PubMed ID: 8030273
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells.
Hodges-Gallagher L; Valentine CD; Bader SE; Kushner PJ
Breast Cancer Res Treat; 2007 Nov; 105(3):297-309. PubMed ID: 17186358
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular pharmacology of antiestrogen action and resistance.
Clarke R; Leonessa F; Welch JN; Skaar TC
Pharmacol Rev; 2001 Mar; 53(1):25-71. PubMed ID: 11171938
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptors in human myeloma cells.
Otsuki T; Yamada O; Kurebayashi J; Moriya T; Sakaguchi H; Kunisue H; Yata K; Uno M; Yawata Y; Ueki A
Cancer Res; 2000 Mar; 60(5):1434-41. PubMed ID: 10728710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
